Latest / Pharmacy Podcast Network / Pharmacists Fight Back Act | PBM Reform Podcast
Transcript
- 0:03Speaker 1: Attention, independent pharmacists. Join the nation's largest independent pharmacy owned
- 0:09Speaker 1: business buying group and strategy cooperative IPC at the NCPA
- 0:13Speaker 1: twenty twenty four Annual Convention and Expo. Mark your calendars
- 0:17Speaker 1: for October twenty sixth through the twenty ninth, twenty twenty
- 0:20Speaker 1: four at the Greater Columbus Convention Center in Columbus, Ohio.
- 0:24Speaker 1: This year's theme growth Performance Success. Don't miss your chance
- 0:29Speaker 1: to connect with the industry leaders, discover innovative solutions, and
- 0:33Speaker 1: elevate your pharmacy's success. Visit us at Booth six P
- 0:36Speaker 1: nineteen to learn how IPC can empower your business. This
- 0:40Speaker 1: is the only national business show designed specifically for independent
- 0:44Speaker 1: pharmacists in their teams. Join us at NCPA twenty twenty
- 0:48Speaker 1: four where your growth for the future of pharmacy begins.
- 0:51Speaker 1: See you there.
- 1:00Speaker 2: You are listening to the global network of podcasters dedicated
- 1:03Speaker 2: to the pharmacy profession. Welcome to the Pharmacy Podcast Network.
- 1:28Speaker 2: Welcome to the PBM Reform Podcast, where we dive deep
- 1:32Speaker 2: into the world of pharmaceutical benefit management, cutting through the
- 1:35Speaker 2: noise to uncover the truth. Since twenty nineteen, we've been
- 1:40Speaker 2: your go to source for the latest on how PBMs
- 1:43Speaker 2: impact patient care, drug pricing, and the very future of pharmacy.
- 1:48Speaker 2: Here we champion the role of pharmacists, the most knowledgeable
- 1:52Speaker 2: advocates for medication safety and expertise join us as we
- 1:57Speaker 2: expose and generate discussions that are re shaping healthcare and
- 2:01Speaker 2: explore how we build a better payment system which focuses
- 2:04Speaker 2: on advancing pharmacy care.
- 2:12Speaker 3: Hey, welcome back to the PBM Reform Podcast. I'm here
- 2:17Speaker 3: today with a group a panel discussion of team leaders
- 2:22Speaker 3: throughout our nation. Specifically, we're going to be focused on
- 2:25Speaker 3: the state of Ohio as a blueprint for moving forward
- 2:29Speaker 3: as a nation and how well the state has done
- 2:33Speaker 3: in the realm of PBM reform and really making pharmacy
- 2:37Speaker 3: care more accessible, fair playing fields for our independent community pharmacies.
- 2:44Speaker 3: The importance of the survival of community pharmacy right now
- 2:49Speaker 3: is accelerated. You see it in the news. We know
- 2:52Speaker 3: through the pharmacy deserts and the data that is coming
- 2:55Speaker 3: back from Health and Human Services throughout the nation through
- 2:58Speaker 3: different states reporting the increased issue that pharmacy deserts are
- 3:04Speaker 3: going to create on public health. Hey, I want to
- 3:08Speaker 3: introduce David Burke. He's the executive director of the Ohio
- 3:12Speaker 3: Pharmacists Association. David, we are thrilled to have you here today.
- 3:17Speaker 4: Todd, thank you very much for having me. Happy to
- 3:19Speaker 4: be here.
- 3:19Speaker 3: I also want to say hello to Mark Kinney. He
- 3:23Speaker 3: is with Independent Pharmacy Cooperative IPC, which is a powerhouse
- 3:29Speaker 3: buying group for the survival and thrive ability of our
- 3:32Speaker 3: independent community pharmacies and really focuses on government affairs and
- 3:37Speaker 3: I love talking with Mark.
- 3:38Speaker 4: Welcome Mark.
- 3:40Speaker 5: Thank you, Todd. Glad to be here.
- 3:42Speaker 3: As well, and kind of a star to us all
- 3:46Speaker 3: if you're a nerd like me about pharmacy and the
- 3:50Speaker 3: realm of PBM reform. If you don't know Antonio Chaco
- 3:55Speaker 3: with three excess advisors in forty six Brooklyn, then you
- 3:59Speaker 3: don't know who is the Jedi master of data interpretation
- 4:03Speaker 3: in the world of PBMs. Antonio Chacha, It's so good
- 4:06Speaker 3: to have you here.
- 4:08Speaker 6: God always a pleasure, my friend.
- 4:12Speaker 3: And just as a side note, this Pittsburgh Steelers are
- 4:15Speaker 3: three and oh right now in the NFL, and Antonio
- 4:19Speaker 3: and I happen to favor of the Pittsburgh Steelers. Even
- 4:22Speaker 3: though I said to Antonio, I don't recognize them, but
- 4:25Speaker 3: I do like watching them play.
- 4:27Speaker 6: Hey, let us all dine on parogis if they become
- 4:30Speaker 6: four and oh.
- 4:33Speaker 3: All right. So we're in a mess people, listeners, you
- 4:38Speaker 3: know this, but we want to bring you up to date.
- 4:41Speaker 3: There's a lot going on. There's a lot of positive
- 4:43Speaker 3: thing things happening in new policy creation based on the
- 4:47Speaker 3: data that we've had that we've been making trying to
- 4:51Speaker 3: make heads or tails out of. And that's where the
- 4:56Speaker 3: data is so important to bring it back to legislators,
- 4:59Speaker 3: but all so interpret it for them, to put it
- 5:02Speaker 3: through a microscope, to let them really drill down into
- 5:05Speaker 3: understanding how that's impacting health and human services and in
- 5:09Speaker 3: public health. There are so many, you know, independent pharmacies
- 5:13Speaker 3: out there, sixteen thousand plus throughout the nation. They're a
- 5:19Speaker 3: drug channel, their care, providing diabetes management. They're digging down
- 5:25Speaker 3: into into very serious disease states. And you know, it's
- 5:33Speaker 3: the system in and of itself that's creating issues. It's
- 5:36Speaker 3: the PBM in of itself. And we've heard a lot
- 5:40Speaker 3: from Antonio that's been giving testimony. You've been featured on
- 5:45Speaker 3: different news programs. I want to start with Mark Kinney
- 5:49Speaker 3: from i PC Mark tell us about the initiatives of
- 5:55Speaker 3: the organization and the specific successes that you've witnessed in
- 5:59Speaker 3: the state of Ohio.
- 6:02Speaker 5: Yeah, Todd, Ohio has actually been on the forefront of
- 6:06Speaker 5: meaningful PBM reform and it couldn't come at a more
- 6:10Speaker 5: crucial time. You talked about the data. We show that
- 6:16Speaker 5: over twenty two hundred community pharmacies have closed across the country,
- 6:21Speaker 5: many of those in Ohio as well. That's independent and
- 6:25Speaker 5: chain pharmacies. But there's a need for putting in some
- 6:31Speaker 5: common sense, reasonable restrictions and regulations on the PBM practices
- 6:38Speaker 5: that are really forcing these local community pharmacies to no
- 6:43Speaker 5: longer be able to provide for their patients in those
- 6:46Speaker 5: local communities. And so I know that Antonio was for
- 6:52Speaker 5: many years one of the first to start looking at that,
- 6:56Speaker 5: and I've worked with Dave bork Now for over a
- 7:00Speaker 5: year on getting PBM reform legislation introduced and hopefully passed.
- 7:06Speaker 5: We have some sponsors Representive bar Horse and Senator Stewart
- 7:11Speaker 5: that have introduced House Built five oh five back in
- 7:16Speaker 5: late late summer, and it's got some really good provisions.
- 7:20Speaker 5: I think some protections that will allow pharmacies to continue
- 7:24Speaker 5: to service those patients in their local communities.
- 7:29Speaker 3: David, as someone who's leading the Ohio State Ohio Pharmacist Association,
- 7:38Speaker 3: where is the State of Ohio in reaching out to
- 7:42Speaker 3: you as an association for that kind of data? Where
- 7:45Speaker 3: are we with PBM reform in the state of Ohio.
- 7:49Speaker 7: We've made some pretty serious progress historically, right we think
- 7:52Speaker 7: about mac legislation regarding the price of drugs. Unfortunately, the PBMs,
- 7:59Speaker 7: as we have learned over time, just simply change the
- 8:02Speaker 7: wording or definition of price or cost and moved around that.
- 8:07Speaker 7: We've done some solid work with audit reform in the
- 8:10Speaker 7: state of Ohio right based on how far back a
- 8:13Speaker 7: PBM can look and what type of things qualify as
- 8:17Speaker 7: a recruitment type of policy.
- 8:21Speaker 4: Those have been substantive.
- 8:24Speaker 7: As Mark mentioned, House Bill five oh five follows in
- 8:27Speaker 7: that pathway right by having a legislative approach to a
- 8:31Speaker 7: kind of Outshall and Outshaw not about problems that representative
- 8:35Speaker 7: bar horses just rightfully pointed out that are painfully as
- 8:38Speaker 7: obvious as when Antonio and I started working on these
- 8:41Speaker 7: issues over.
- 8:41Speaker 4: A decade ago.
- 8:43Speaker 7: But we're leading a two prong approach here in Ohio.
- 8:45Speaker 7: So it's not just the legislative approach like most states
- 8:48Speaker 7: have done. We are building a regulatory bill with our
- 8:53Speaker 7: Attorney General and the Department of Insurance to regulate PBMs
- 8:58Speaker 7: as the entity that they are currently under Ohio law,
- 9:02Speaker 7: they are third party administrators. But I think anybody who's
- 9:05Speaker 7: touched this market realizes that PBMs don't just administer. Although
- 9:10Speaker 7: they're not quite insurers either, right, they kind of fall
- 9:13Speaker 7: into their own bucket. And that is the approach we're taking,
- 9:15Speaker 7: and we're working in through regulatory agencies to oversee this
- 9:19Speaker 7: and add transparency to this marketplace.
- 9:24Speaker 3: Thank you so much, and Antonio, you have been on
- 9:28Speaker 3: the news, You've been brought into testimony, there are quotes
- 9:34Speaker 3: being made publicly that are extracting data from your firms,
- 9:38Speaker 3: and very proud of what you've done. Pharmacy Benefit Management
- 9:42Speaker 3: reform has really emerged as this bipartisan issue. It's you know,
- 9:49Speaker 3: Congress is coming together finally, both Republicans and Democrats have
- 9:53Speaker 3: advanced that myriad of bills that would begin to address
- 9:56Speaker 3: PBMs and the lack of transparency and the misalignment of
- 10:01Speaker 3: why even make the money that they are and the
- 10:03Speaker 3: profits that they are. We know that the FTC is
- 10:07Speaker 3: now digging in and putting teeth into this, and you've
- 10:10Speaker 3: made comments on that. Give us an overview. Let's start
- 10:13Speaker 3: with with the success of Ohio first, and then we'll
- 10:18Speaker 3: of course unpack other things that are going to are
- 10:20Speaker 3: going to impact the nation.
- 10:23Speaker 6: Thanks Todd. You know, like any story, start at the beginning,
- 10:27Speaker 6: right And when I started the Ohio Pharmacists Association in
- 10:30Speaker 6: twenty ten, you know, it was really just about triaging
- 10:36Speaker 6: complaints from pharmacists about a variety of matters that we're
- 10:40Speaker 6: impacting the profession, PBMs being one of the most significant.
- 10:43Speaker 6: The pharmacists, like any other profession, encounter many challenges that
- 10:48Speaker 6: you know, they are not necessarily paid commensurate with their value.
- 10:53Speaker 6: The way that they're paid doesn't necessarily incentivize the things
- 10:56Speaker 6: that we want them to do. And so you had
- 10:59Speaker 6: this greater problem of a misalignment of paying for what
- 11:03Speaker 6: we want pharmacists to actually achieve for a patient and
- 11:06Speaker 6: broader public health goals. And so as we tried to
- 11:10Speaker 6: do that, we realized, you know, not only are they
- 11:13Speaker 6: not being paid the right way, but at the time,
- 11:15Speaker 6: they weren't being paid enough to even exist So what
- 11:19Speaker 6: good is an incentive alignment if there is no actual
- 11:23Speaker 6: bandwidth for incentive. And the problem in Ohio was that
- 11:27Speaker 6: as pharmacies were being underpaid for what they were doing
- 11:32Speaker 6: in the Medicaid program. I understand that obviously in a
- 11:36Speaker 6: very pharmacy centered podcast, we want to talk about the
- 11:39Speaker 6: impact to the pharmacist. But the other on the other
- 11:42Speaker 6: end of the transaction is a series of taxpayers that
- 11:45Speaker 6: are putting the bill to drive pharmacies out of business.
- 11:49Speaker 6: And it would be one thing if taxpayers were finding
- 11:51Speaker 6: value in that underpayment, but that's not what was occurring.
- 11:55Speaker 6: As pharmacies were being underpaid for what they did, the
- 11:58Speaker 6: state was simultaneously being overcharged for those same transactions. That's
- 12:05Speaker 6: right around the time when I started working very closely
- 12:08Speaker 6: with Dave Burke. Dave before he was running the Ohio
- 12:12Speaker 6: Pharmacists Association. Dave was a state representative and a state Senator,
- 12:17Speaker 6: and perhaps most importantly, Dave was one of the people
- 12:20Speaker 6: that created the Joint Medicaid Oversite Committee, which is such
- 12:25Speaker 6: a joint venture of the House and the Senate. But
- 12:28Speaker 6: the idea that medicaid as a standalone marketplace was complicated
- 12:33Speaker 6: enough that it required a special degree of overstate from
- 12:37Speaker 6: lawmakers because historically the executive branch of government was either
- 12:42Speaker 6: not giving lawmakers the information they need to hold the
- 12:45Speaker 6: program accountable, or they were resistant to changes right they
- 12:49Speaker 6: would just prefer to run it their own way, And
- 12:52Speaker 6: so Dave running the Joint Medicaid Oversite Committee was a
- 12:56Speaker 6: key facilitator in driving demands for increase information for what
- 13:02Speaker 6: was actually happening in that Medicaid program. That occurred concurrently
- 13:06Speaker 6: with the Columbus Dispatch beginning their investigations and US crunching
- 13:11Speaker 6: our data that ultimately unearthed this two hundred and forty
- 13:14Speaker 6: five million dollar asymmetry of information between pharmacies being paid
- 13:19Speaker 6: very low and the state then build very high. And
- 13:23Speaker 6: then over the course of that the state said, hey,
- 13:26Speaker 6: let's ban spread pricing because we don't want to lose
- 13:29Speaker 6: this value to the intermediary while pharmacies are going out
- 13:32Speaker 6: of business. What we quickly learned is what pharmacists have
- 13:35Speaker 6: been talking about for quite some time, and it is
- 13:37Speaker 6: a phrase that is constantly uttered in state legislatures and
- 13:41Speaker 6: in congress alike. Is this game of whack a mole.
- 13:45Speaker 6: You close one hole only to learn that there are
- 13:49Speaker 6: many other holes in that system, giving way to effective
- 13:53Speaker 6: rate clawbacks, dr fees, specialty pharmacy, overcharging, and steering. All
- 14:00Speaker 6: of these things are different forms of what I would
- 14:03Speaker 6: call lowercase s spread pricing. That is, finding ways to
- 14:08Speaker 6: buy low, sell high, and create advantages that may not
- 14:13Speaker 6: necessarily be felt equitably across the entire pharmacy marketplace. So
- 14:18Speaker 6: Ohio has been a great catalyst, no doubt, largely not
- 14:23Speaker 6: because of anything intrinsically special other than demanding answers for
- 14:28Speaker 6: questions that had been previously unanswered.
- 14:34Speaker 3: That makes sense, and you know, the the Attorney General
- 14:40Speaker 3: Yosts has just been amazing at an understanding and collective
- 14:46Speaker 3: from all the data to be able to come out
- 14:49Speaker 3: with decisions to impact the state of Ohio. And it's
- 14:52Speaker 3: being watched by the rest of the nation. Expand upon
- 14:58Speaker 3: to David Burke or just what work you've done and
- 15:02Speaker 3: the information that you've been able to help generate for
- 15:08Speaker 3: organizations and even Attorney General yost what have you shown
- 15:14Speaker 3: from the pharmacy care perspective, the independent pharmacy perspective that
- 15:20Speaker 3: this is impacting coverage, it's impacting pharmacy deserts. What other
- 15:25Speaker 3: things have you supplied the state of Ohio.
- 15:28Speaker 7: So certainly the Medicaid Oversight Committee brought a lot of
- 15:33Speaker 7: these things to light, as Antonio mentioned that we're going
- 15:36Speaker 7: on in the state of Ohio and disparity between I
- 15:40Speaker 7: guess to answer your question globally, this cost charge issue
- 15:45Speaker 7: with drugs in the Attorney General Dave Jos quickly realized,
- 15:49Speaker 7: right that the drugs are single source items for the
- 15:53Speaker 7: most part, even generics have a limited capacity. But under
- 15:56Speaker 7: federal law, a drug X is drug X in Ohio, Io,
- 16:00Speaker 7: as it is in California, as it is in New York,
- 16:02Speaker 7: and they're also in the country. So there's almost a
- 16:04Speaker 7: utility kind of process, right that goes on with drugs
- 16:08Speaker 7: if you if you look at them that way. Antonio
- 16:10Speaker 7: cha Ja broke down what has been this price differential over?
- 16:15Speaker 7: Why is something is the same thing no matter where
- 16:17Speaker 7: you go to get it, is the price so different?
- 16:21Speaker 7: And it's not ten dollars at one place and twenty
- 16:23Speaker 7: in another. It's ten dollars at one place and one
- 16:26Speaker 7: thousand dollars at another, And why is this happening?
- 16:30Speaker 4: Right?
- 16:31Speaker 7: So, Dave Yost, I think you know, like myself and
- 16:34Speaker 7: Antonio in Mark We believe in competitive markets, but competitive
- 16:39Speaker 7: markets require transparency.
- 16:41Speaker 4: And not only is the taxpayer.
- 16:43Speaker 7: Being hurt as Antonio talked about within the state Medicaid system,
- 16:46Speaker 7: the average person is also being hurt because it's driving
- 16:49Speaker 7: out business, it's limiting capacity of the pharmacy market. Look
- 16:53Speaker 7: no further than the recent Walgreens story and then potentially
- 16:56Speaker 7: closing up to twenty five percent of their locations after
- 17:00Speaker 7: assuming and closing Rite Aid stores. And to double down
- 17:04Speaker 7: on that, that's a geographic desert. How about the contractual
- 17:08Speaker 7: deserts that Antonio touched on right, where my pharmacy simply
- 17:11Speaker 7: isn't in that network, or if it is, it's fifty
- 17:15Speaker 7: dollars to come to my store, but the store that's
- 17:18Speaker 7: ten miles away, for example, is a zero copay. I
- 17:21Speaker 7: would argue that's very much a desert because somebody who's
- 17:24Speaker 7: on four or five different medications that's two to three
- 17:26Speaker 7: hundred dollars a month versus zero.
- 17:29Speaker 4: I mean, they're not going to come to my pharmacy.
- 17:31Speaker 7: So what we really want to do here in Ohio
- 17:33Speaker 7: with the Attorney General's lawsuits focus on, are having payers
- 17:38Speaker 7: and insurers meaning health plans being able to look at
- 17:43Speaker 7: the prescription drug benefit and it means the same thing
- 17:47Speaker 7: PBM to PBM and company to company. Not I'm going
- 17:50Speaker 7: to save you twenty million dollars, I'm going to save
- 17:53Speaker 7: you thirty million if you go with me. Now, how
- 17:55Speaker 7: about the price of prescriptions and the risk adjustment? The
- 17:59Speaker 7: actual real base for that portion of the health benefit,
- 18:03Speaker 7: just like any other health benefit is based when it
- 18:06Speaker 7: comes to building a premium. That's the competitive market that
- 18:09Speaker 7: we want pharmacy to find. In that market, I believe
- 18:12Speaker 7: independence will thrive because their service value is much higher
- 18:16Speaker 7: and their ability to operate in that business environment is
- 18:19Speaker 7: less expensive. So to me, patients win right when we
- 18:23Speaker 7: have a competitive market and independent pharmacy is a direct
- 18:26Speaker 7: beneficiary of that versus the environment we have today that's
- 18:30Speaker 7: contractually restrictive and cost prohibitive and clearly increases the price
- 18:35Speaker 7: of the product that the patient needs to avoid a
- 18:39Speaker 7: higher cost health setting.
- 18:43Speaker 3: Mark. There have been bills that have come in front
- 18:48Speaker 3: of State Congress that one of them is called the
- 18:52Speaker 3: Drug Act, the other is the Protecting Patients against PBM
- 18:55Speaker 3: of Abuses Act, and there's another one, Lower Cost More
- 19:00Speaker 3: Transparency Act. I think of this all rolling up to
- 19:04Speaker 3: what is now known as the Pharmacist Fight Back Act,
- 19:08Speaker 3: which is being led by our the state representative, Jake.
- 19:14Speaker 6: Congressman Jake Hawkinclaus. Yes, learn the name because you're going
- 19:18Speaker 6: here for a long time.
- 19:19Speaker 3: Watching I love him and I watch him on TikTok
- 19:22Speaker 3: So and Diane Harshberger from Tennessee. So talk to us
- 19:27Speaker 3: Mark about that, the Pharmacist Fight Back Act and what
- 19:33Speaker 3: kind of inclusiveness because I think of IPC. I think
- 19:36Speaker 3: of IPC gathering up four thousand and five thousand independent
- 19:40Speaker 3: pharmacy owners and understanding, being educated, and then being able
- 19:44Speaker 3: to take action, whether that's flying into Washington, d C.
- 19:48Speaker 3: Meeting with policymakers, or just inviting people into their own
- 19:52Speaker 3: pharmacies to really review impact of lack of pharmacy access.
- 19:58Speaker 3: But expand upon that from from your perspective, Mark.
- 20:02Speaker 5: Yeah, Todd, you're absolutely right. On a federal level, I
- 20:07Speaker 5: think there's a bipartisan understanding that Congress needs to act.
- 20:13Speaker 5: There needs to be some regulation of these egregious business
- 20:18Speaker 5: practices that we find ourselves having to deal with. And
- 20:22Speaker 5: when I go out to Washington, D C. And we
- 20:25Speaker 5: had a fly in, we flew in our board of
- 20:27Speaker 5: Directors and our senior management team, and we went up
- 20:31Speaker 5: on the hill back in March and met with these
- 20:35Speaker 5: uh these folks including uh Dinah Harsbarger, Buddy Carter and
- 20:44Speaker 5: others that are clear UH pharmacy advocates, and they get it.
- 20:50Speaker 5: And what's interesting is, you know, five years ago when
- 20:54Speaker 5: I went up on the hill, sometimes people there they're
- 20:58Speaker 5: eyes glazed over because it's it's pretty complicated, right and
- 21:02Speaker 5: by design, by design, it's complicated and it's not transparent.
- 21:07Speaker 5: And so you know, today when we go up there,
- 21:10Speaker 5: everyone understands, you know, what PBMs are doing and why
- 21:14Speaker 5: there needs to be you know, something something done. And
- 21:17Speaker 5: I think Senate Finance Committee with their Modernizing and Ensuring
- 21:23Speaker 5: PBM Accountability Act, that Center Bill twenty nine seventy three
- 21:28Speaker 5: was really the first out of the gate to you know,
- 21:32Speaker 5: take a hard look at this and and part of
- 21:35Speaker 5: that legislation would require transparent cost based reimbursement for Medicaid programs,
- 21:42Speaker 5: eliminating spread pricing that Antonio referred to before, and then
- 21:48Speaker 5: also having standardized performance standards for reimbursing pharmacist for clinical outcomes.
- 21:55Speaker 5: And you know that that was a really good start
- 21:58Speaker 5: and then send it to help and Commerce. They also
- 22:02Speaker 5: had hearings in the and Committee legislation that was passed,
- 22:09Speaker 5: and one of the really important pieces of that legislation
- 22:13Speaker 5: coming out of Senate Commerce was fair and Relevant reimbursement
- 22:17Speaker 5: for pharmacies and that of course includes you know, cost based,
- 22:22Speaker 5: transparent reimbursement that everyone can see, it's not you know,
- 22:27Speaker 5: behind a smoke screen, and we think that that's real
- 22:30Speaker 5: good legislation as well.
- 22:34Speaker 6: Well.
- 22:34Speaker 5: When you talk about Representative Auction Class, that bill was
- 22:39Speaker 5: introduced relatively late, just a few months ago. It includes
- 22:43Speaker 5: some tremendous provisions that we certainly support, and I would
- 22:47Speaker 5: agree we're going to hear a lot more from Representative
- 22:51Speaker 5: and Class. He's very well spoken, articulates smart, he gets
- 22:56Speaker 5: the issues, and we're very supple word of you know,
- 23:00Speaker 5: what he's doing. And others in the you know, the House,
- 23:04Speaker 5: they continue to have, you know, votes on PBM's bill,
- 23:09Speaker 5: and if you remember, the House actually passed PBM reform
- 23:14Speaker 5: legislation and it got caught up in the Senate, and
- 23:19Speaker 5: so we we were trying to, uh, you know, figure
- 23:22Speaker 5: out what we can do to kind of uh loosen
- 23:26Speaker 5: the log jam a little bit there, and you know,
- 23:29Speaker 5: Senator Schumer he had some concerns more about hospitals, not
- 23:33Speaker 5: about the PBM piece and Center Cassidy from Louisiana. He
- 23:38Speaker 5: didn't feel like the bill went far enough, meaning that
- 23:42Speaker 5: the Senate Health Bill, not the you know, represented Auction
- 23:47Speaker 5: Classes bill, which still has to move. But you know, again,
- 23:51Speaker 5: we even those two senators now recognize that, you know,
- 23:58Speaker 5: you know, we got to do something. My concern though, is,
- 24:02Speaker 5: you know, we're running out of time in this Congress,
- 24:06Speaker 5: and this Congress has not passed a lot of bills
- 24:09Speaker 5: based upon a historical basis, and we're really looking at
- 24:13Speaker 5: probably lane duck session after the election, maybe thirty days
- 24:19Speaker 5: or a few more than that to get something done.
- 24:22Speaker 5: And Representative I should call him Speaker Johnson just this
- 24:28Speaker 5: week said that, well, his main focus is just getting
- 24:32Speaker 5: a continuing resolution to fund the government done. His words were,
- 24:38Speaker 5: you know, I'm not sure if we're going to be
- 24:39Speaker 5: able to really address some of the other legislation that
- 24:44Speaker 5: needs to be passed. That was a little bit disconcerting
- 24:48Speaker 5: to hear. But at the same time, Senator Wyden, who
- 24:52Speaker 5: heads Upsentate Finance, said this is still our number one priority.
- 24:56Speaker 5: Is we need to get PBM reform passed. We need
- 24:59Speaker 5: to get it passed this Congress. And so you know,
- 25:04Speaker 5: we we still think we got some you know, good
- 25:07Speaker 5: movements on the House side. May you may have seen
- 25:11Speaker 5: the UH hearing that's Chairman Comer from the House Accountability
- 25:18Speaker 5: UH Committee had an oversight and that was I don't
- 25:23Speaker 5: know if you had a chance to see that, but
- 25:25Speaker 5: they brought the three big p b M CEOs in
- 25:29Speaker 5: h asked them some tough questions and you know, that
- 25:33Speaker 5: went on for about four hours and and I'm not
- 25:36Speaker 5: sure if the committee got the answers that they were
- 25:39Speaker 5: really looking for. And then I'd also point out that
- 25:42Speaker 5: this week Senator Bernie Sanders had the CEO and Novo
- 25:48Speaker 5: Nordisk int you know, talk to them that committee. And
- 25:53Speaker 5: one of the questions that Senator Sanders asked and was,
- 25:56Speaker 5: you know, why does Ozembic cost in the United States
- 26:00Speaker 5: nine hundred and sixty dollars for thirty days, where in Denmark,
- 26:04Speaker 5: where that company is headquartered, it only costs around one
- 26:08Speaker 5: hundred and sixty dollars, and oddly enough, in Germany it's
- 26:11Speaker 5: only fifty six dollars. And the response that the CEO
- 26:16Speaker 5: gave was because you have PBMs, and so that's that
- 26:20Speaker 5: should be a wake up call for everyone that you
- 26:23Speaker 5: know high prescription drug costs. I mean, you can point
- 26:27Speaker 5: the fingers that maybe a lot of channel participants, but
- 26:32Speaker 5: PBMs have a big role in that.
- 26:36Speaker 3: Yes, Antonio, you and I have talked so many other times.
- 26:39Speaker 3: I've listened to you read your reports. I can understand
- 26:43Speaker 3: about half of it with all the complexity that's baked
- 26:46Speaker 3: into the existing standards that are in place for PBMs
- 26:54Speaker 3: to act. But I try to simplify things, especially for
- 26:58Speaker 3: the layperson, is to just describe to them why this
- 27:01Speaker 3: is so important to vote for certain things and for
- 27:04Speaker 3: certain representatives either Senator or House within your state. The
- 27:09Speaker 3: three things we know that this act, this Pharmacist Fight
- 27:13Speaker 3: Back Act, implements a transparent pharmacy reimbursement model using market
- 27:17Speaker 3: based pricing benchmark to the national average drug acquisition costs
- 27:22Speaker 3: or not act and then a dispensing fee. And then
- 27:26Speaker 3: the next thing removes the ability for PBMs to restrict
- 27:29Speaker 3: patient choice via networking exclusions, and then finally protects community
- 27:35Speaker 3: pharmacists by prohibiting PBMs from steering patients to PBM affiliated
- 27:40Speaker 3: pharmacies Josh Shapiro signed into law a win for Pennsylvania.
- 27:47Speaker 3: I don't think it went far enough, But talk to
- 27:50Speaker 3: us about you being able to stand back with everything
- 27:53Speaker 3: that you know. Where are the holes? Where are the
- 27:56Speaker 3: leaky holes that the PCMA and the teams that are
- 28:00Speaker 3: fighting for PBMs not to lose their grip? Where are
- 28:04Speaker 3: some of the holes that you could shout out on
- 28:06Speaker 3: the podcast to just give everybody kind of heads up
- 28:09Speaker 3: of where you see things going next.
- 28:12Speaker 6: Yeah, I mean, look, I think I think if I
- 28:15Speaker 6: was to take a PBM oriented view of the world,
- 28:17Speaker 6: and let's pretend that I was not using my market
- 28:20Speaker 6: power to create advantages at the expense of a broader
- 28:24Speaker 6: public health goals or a fair or competition, the three
- 28:29Speaker 6: things that Congress is really staring at is saying, Hey,
- 28:33Speaker 6: we don't like the way you're setting the prices, we
- 28:37Speaker 6: don't like the way that you're leaning into your conflicts
- 28:41Speaker 6: of interest, and we don't like how you're creating advantages
- 28:47Speaker 6: in disadvantages for different pharmacies, not based on anything relevant
- 28:53Speaker 6: from a clinical perspective, but merely based upon the casino
- 28:57Speaker 6: of chance of how reimbursements fit out at the end.
- 29:01Speaker 6: What that means is that in every study we've done
- 29:04Speaker 6: of examining pharmacy reimbursement and on the flip side, in
- 29:07Speaker 6: every study we've done examining what plant sponsors are being
- 29:10Speaker 6: charged for pharmacy transactions, what you see is that very
- 29:14Speaker 6: often PBMs are providing what many would call a great deal.
- 29:19Speaker 6: On the pharmacy side, that would mean a very low
- 29:21Speaker 6: rate of reimbursement, largely unsustainable. And then there's other claims
- 29:25Speaker 6: where the PBMs are providing reasonable compensation perhaps and again
- 29:31Speaker 6: on the flip side, a reasonable rate of bill to
- 29:33Speaker 6: the plant sponsor. But then you have this ten or
- 29:37Speaker 6: five percent of claims that wildly overpay pharmacies and thus
- 29:42Speaker 6: wildly overcharged plant sponsors. So what's happening is that every
- 29:47Speaker 6: pharmacy that I've ever talked to, it tells me, you know, hey,
- 29:51Speaker 6: I'm in big trouble. But when I look at the numbers, right,
- 29:55Speaker 6: I'll see issue I'll see is this is where the
- 29:57Speaker 6: same pharmacies operating in the same state at the same time,
- 30:01Speaker 6: one could be running deep in the red and the
- 30:04Speaker 6: other could be pretty sustainable. Right, And we see this
- 30:07Speaker 6: on the plan sponsor side that when you look at
- 30:10Speaker 6: what they're being charged, you can see that some pharmacies
- 30:14Speaker 6: based upon that data, probably doing very well and some
- 30:17Speaker 6: are doing quite poorly. That all stems from the inconsistent way,
- 30:22Speaker 6: in disconnected way that PBMs ultimately set the rates of
- 30:26Speaker 6: compensation and what they build for. So I think in
- 30:30Speaker 6: general most people would say we should let the market
- 30:33Speaker 6: kind of go as it is right, say, let them
- 30:35Speaker 6: negotiate a low rate of reimbursement or whatever the market
- 30:39Speaker 6: will bear, and let them decide, you know, what a
- 30:41Speaker 6: pharmacy network would look like, and without saying whether that's
- 30:46Speaker 6: philosophical right or wrong, what we see in the data
- 30:49Speaker 6: is that those allowances create massive asymmetry of alignment of
- 30:54Speaker 6: incentives from a payer and a pharmacy perspective, meaning that
- 31:00Speaker 6: the same pharmacy can dispense the same drug right from
- 31:04Speaker 6: one minute to the next and be paid anywhere from
- 31:07Speaker 6: nine dollars to ninety dollars. That is the inconsistency that
- 31:10Speaker 6: we see with how PBMs compensate. And again we see
- 31:13Speaker 6: the same things on the plant sponsor side. So unfortunately
- 31:16Speaker 6: a lot of the pharmacies that get driven out of business,
- 31:19Speaker 6: it's not because they run a bad pharmacy. It's not
- 31:22Speaker 6: because their patients don't want to go there. It's not
- 31:25Speaker 6: even because of anything that has to do with any
- 31:27Speaker 6: service that they offer. It is merely a spin of
- 31:30Speaker 6: a roulette wheel on what can cause one pharmacy to
- 31:34Speaker 6: become enriched and another to become poor. The thing that
- 31:38Speaker 6: we see consistently though, is that the pharmacies that are
- 31:42Speaker 6: best positioned to succeed just so happen to be the
- 31:44Speaker 6: pharmacies that are owned by the PBM. So when you
- 31:48Speaker 6: talk about the potential leakage, right, policy is always going
- 31:53Speaker 6: to be works in progress, right. And we often see
- 31:56Speaker 6: PBMs contort the way that they do their tricks such
- 32:01Speaker 6: that they could keep the money flowing, keep the same
- 32:04Speaker 6: money flowing, but perhaps harvest it in a different way.
- 32:08Speaker 6: So I think what you're trying, what you're seeing Congress
- 32:11Speaker 6: attempt to do without trying to go overboard, is to say,
- 32:15Speaker 6: we don't think you've used your power in ways that
- 32:19Speaker 6: are consistent with what we believe is an aligned marketplace
- 32:22Speaker 6: for better health, better access, and lower costs. And so,
- 32:26Speaker 6: whether it's the Aucken cost Bill, or the Senate Finance
- 32:30Speaker 6: Committee or any of the other bills that you're seeing
- 32:32Speaker 6: in Congress. All of them are trying to remedy these
- 32:36Speaker 6: fundamental flaws that have been allowed by vertical integration and
- 32:41Speaker 6: subjective setting of prices by the price by somebody who
- 32:46Speaker 6: is ultimately a price taker as well.
- 32:51Speaker 3: Yes, and that, of course we're seeing the domino effect
- 32:55Speaker 3: of these practices of the PBMs in and now it's
- 33:01Speaker 3: eating their own CVS health in the PBM that they run,
- 33:08Speaker 3: is causing not only the burnout that we experienced or
- 33:12Speaker 3: especially heightened during the pandemic, but they're closing their own
- 33:15Speaker 3: stores because they can't operate at a profit in these stores,
- 33:20Speaker 3: so they're just closing them and they're moving on. And
- 33:23Speaker 3: of course that's trickled out into the chapter eleven situation
- 33:27Speaker 3: that Rite Aid's coming out of, is what David was
- 33:30Speaker 3: saying with the closings of Walgreens. And then of course
- 33:35Speaker 3: the pressure that's putting on our independent community pharmacies closing
- 33:39Speaker 3: throughout the nation and different states more than others. So
- 33:43Speaker 3: what's the next step in a pharmacist owner's playbook in
- 33:50Speaker 3: Ohio but also nationally. Mark, It's interesting to talk with
- 33:55Speaker 3: you because you do have enough of a client base
- 34:02Speaker 3: a customer base that owns i PC owned by pharmacy
- 34:06Speaker 3: owners to be able to understand what states are strengthening
- 34:13Speaker 3: and what states are are weakening based on PBM reform,
- 34:17Speaker 3: based on policy creation. So in wrapping up the conversation, Mark,
- 34:22Speaker 3: you know, just give us an overview of what you're coaching.
- 34:27Speaker 3: Is for the pharmacy owners that are listening.
- 34:31Speaker 5: Yeah, Todd, I think it's important for them to get
- 34:34Speaker 5: engaged in the process. And I think David can speak
- 34:38Speaker 5: to it as well. Being a pharmacy owner and also
- 34:42Speaker 5: a legislator is that, you know, you have to get
- 34:45Speaker 5: involved as the number one thing, and we see that
- 34:48Speaker 5: in states that have strong pharmacy advocacy efforts, they're in
- 34:54Speaker 5: a better position than maybe others. But and it's difficult
- 34:58Speaker 5: for our pharmacy owners there, you know, behind the bench,
- 35:02Speaker 5: you know, filling prescriptions. It's it's hard to step away,
- 35:06Speaker 5: but it's almost got to be part of your business model,
- 35:10Speaker 5: right and getting engaged and participating in the process is
- 35:16Speaker 5: really the most important thing that you know, our pharmacy
- 35:20Speaker 5: members can do. We also, you know, educate them on
- 35:24Speaker 5: diversifying revenue streams and not looking at just traditional dispensing
- 35:31Speaker 5: of prescription medications. But you know, looking at compounding, looking
- 35:35Speaker 5: at three pointy b looking at vaccinations, all these things
- 35:40Speaker 5: can help support the pharmacy and and to be honest,
- 35:46Speaker 5: they're going to have to do that in order to
- 35:49Speaker 5: continue to thrive out there. But I would say that,
- 35:54Speaker 5: you know, the pharmacy deserts that are being created across
- 35:57Speaker 5: the country has got to be a concern for everyone,
- 36:02Speaker 5: and I believe that that's really driving I think the
- 36:06Speaker 5: policy decisions and the state legislation that you know receive
- 36:11Speaker 5: because we've had some really great wins out in the States,
- 36:16Speaker 5: because they understand that accessibility patient accessibility to prescription medications
- 36:22Speaker 5: is really important, and yet it seems to be going away.
- 36:25Speaker 5: So those are the things that i PC is asking
- 36:28Speaker 5: of their membership, and the great news is they're responding.
- 36:32Speaker 5: They really are getting involved, and it's it's you know,
- 36:36Speaker 5: it's exciting to see. Again. I've been in this business
- 36:39Speaker 5: for thirty years now, and for them, you know, this
- 36:43Speaker 5: is the most I've seen pharmacies get get involved in
- 36:47Speaker 5: the political process talking to their elected officials. And one
- 36:52Speaker 5: of the most important things they can do is actually
- 36:55Speaker 5: bring that elected official into their pharmacy, so they can
- 36:59Speaker 5: see how the pharmacy works in the community, how they
- 37:03Speaker 5: interact with those local patients. Many times multi generational coming
- 37:09Speaker 5: into that pharmacy. Families that the pharmacy may have been
- 37:14Speaker 5: their fifty sixty, seventy years, and that's where people go
- 37:18Speaker 5: to get their healthcare, especially in rural areas of America.
- 37:22Speaker 5: So but there's things that can be done. There's certainly
- 37:27Speaker 5: successful pharmacies out there, and I expect to continue to
- 37:32Speaker 5: see that in the future.
- 37:35Speaker 3: I like hearing the generation of revenue for our community
- 37:38Speaker 3: pharmacies that's not attached to a dispensing fee. I also
- 37:42Speaker 3: predict that through the exercise that the nation is going
- 37:47Speaker 3: through and the extra assistance that the FTC is digging
- 37:51Speaker 3: into PBMs and PBM reform, we're going to come to
- 37:55Speaker 3: a day and I hope it's sooner than later that
- 37:58Speaker 3: the dispensing fee will not be the primary source of
- 38:02Speaker 3: paying for pharmacy care. But it's going to be where
- 38:05Speaker 3: CMS says that's it now. This is going to accelerate
- 38:09Speaker 3: provider status and we're going to start paying pharmacists whether
- 38:12Speaker 3: they dispense or not dispense, based on the expertise that
- 38:17Speaker 3: they're bringing to the table to dig into that condition,
- 38:19Speaker 3: to dig into that disease state, in saying, if you
- 38:24Speaker 3: dispense this med you get paid X.
- 38:27Speaker 4: Okay, that's great.
- 38:29Speaker 3: What if the pharmacist looked at the chart of that
- 38:32Speaker 3: patient or the medication list of that patient and they said, actually,
- 38:36Speaker 3: I don't want to dispense this because I don't think
- 38:38Speaker 3: this is good for you as an individual with what
- 38:42Speaker 3: you have going on. I'm going to contact your physician.
- 38:44Speaker 3: We're going to talk about it, but I'm not dispensing
- 38:46Speaker 3: the drug. Does that mean that the pharmacist that just
- 38:49Speaker 3: spent thirty minutes or an hour with this patient makes
- 38:53Speaker 3: zero dollars? And in today's model, that unfortunately is the case.
- 38:57Speaker 3: So other healthcare services that are generating I'm thinking of
- 39:01Speaker 3: DME services. I'm thinking of coaching services around diabetes or hypertension.
- 39:07Speaker 3: I'm thinking of home health, the expansion of home health
- 39:10Speaker 3: and bringing health to the individual's home. They can't go
- 39:15Speaker 3: to a nursing home or there is no long term
- 39:17Speaker 3: care facility, and now they want to age and they
- 39:20Speaker 3: want to stay in place. So the evolution of PBMs,
- 39:25Speaker 3: I certainly don't think they're going to give up. There's
- 39:27Speaker 3: just too much money to be made. But I do
- 39:29Speaker 3: see it shifting in the way things are being paid,
- 39:32Speaker 3: as well as the classification of how data is being
- 39:37Speaker 3: used and how pricing mechanisms are being used, and definitely
- 39:41Speaker 3: transparency comes into play. So this is very important for us.
- 39:46Speaker 6: Well, don real quick. I mean, one of the greatest
- 39:48Speaker 6: success stories of OHIO is one that we didn't even
- 39:50Speaker 6: talk about, which is in Ohio's push to neutralize the
- 39:55Speaker 6: PBM payment problem. Again, regardless of whether pharmacists are paid
- 39:58Speaker 6: too much, too little, or between right, having a consistent
- 40:02Speaker 6: approach to reinforcement ultimately means the smoothing of incentives, so
- 40:06Speaker 6: you don't have to worry about the losses and you
- 40:08Speaker 6: don't have to seek out the winners in order to
- 40:10Speaker 6: maximize your business. By creating a standardized approach to pharmacy
- 40:14Speaker 6: compensation for dispensing, now you have a foundation with which
- 40:17Speaker 6: you can start building new incentives on top of So
- 40:20Speaker 6: before Dave left the legislature, one of the very last
- 40:23Speaker 6: things that he worked on, and I got to add
- 40:25Speaker 6: the great portune of working with him on this as well,
- 40:28Speaker 6: was advancing pharmacist provider status in the State of Ohio, Right,
- 40:32Speaker 6: pharmacists do much more than dispense drugs. They need to
- 40:36Speaker 6: be compensated for dispensing drugs, but they have so much
- 40:40Speaker 6: more to offer the healthcare delivery system. If you do
- 40:43Speaker 6: not pay them for those clinical services, don't be surprised
- 40:47Speaker 6: if they are not offered, especially when you're not paying
- 40:50Speaker 6: enough to sustain the dispensing business. So to me, PBM
- 40:54Speaker 6: reform from a pharmacy perspective, again without taking sides on
- 40:58Speaker 6: how much you pay a pharmacy. You have to have
- 41:01Speaker 6: a consistent approach to consistently rendered services, in this case dispensing,
- 41:07Speaker 6: such that you can layer on the additional things that
- 41:10Speaker 6: you want pharmacists to do that can drive even greater
- 41:13Speaker 6: value than the model that we had of yesterday.
- 41:17Speaker 3: It's incredible.
- 41:19Speaker 2: Mark.
- 41:19Speaker 3: I want to say thank you to you into IPC
- 41:22Speaker 3: for putting this panel together and bringing Antonio and David
- 41:27Speaker 3: to the microphone, and how important that this is at
- 41:30Speaker 3: this stage in the history of pharmacy care and how
- 41:34Speaker 3: Ohio's leading. But we're going to take Ohio's blueprint and
- 41:38Speaker 3: spread it throughout the rest of the nation. But I
- 41:40Speaker 3: just wanted to say thank you, Mark, Into you and IPC.
- 41:45Speaker 4: Yeah.
- 41:45Speaker 5: Thanks, It's always a pleasure and we look forward to
- 41:50Speaker 5: doing it again.
- 41:52Speaker 3: All right, if you have any questions, please reach out.
- 41:55Speaker 3: We're going to have some links in the show notes,
- 41:57Speaker 3: so if you're driving or you're doing something that you
- 42:00Speaker 3: are just listening, don't worry, go back to your favorite
- 42:03Speaker 3: podcast player. Inside the show notes, you'll be able to
- 42:06Speaker 3: reach out for more information. We're going to include access
- 42:10Speaker 3: to the i PC contact sheets as well as access
- 42:15Speaker 3: for connecting with the Ohio Pharmacists Association and Antonio Mark David,
- 42:23Speaker 3: this has been wonderful and we thank you for your insights.
- 42:26Speaker 5: To you, Thanks Doud